What does CUSIP 04280A100 represent in this 13F holders report?

CUSIP 04280A100 is the security identifier for ARWR - ARROWHEAD PHARMACEUTICALS, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held ARWR - ARROWHEAD PHARMACEUTICALS, INC. - Common Stock in Q2 2018?

114 institutional investors reported ARWR - ARROWHEAD PHARMACEUTICALS, INC. - Common Stock for Q2 2018. Use the holders table for investor-level position and value details.

ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (ARWR)

CUSIP: 04280A100

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class: Equity / Common Stock
Shares outstanding: 135,488,140
Total 13F shares: 51,724,461
Share change: +11,160,619
Total reported value: $703,394,391
Put/Call ratio: 81%
Price per share: $13.60
Number of holders: 114
Value change: +$174,211,743
Number of buys: 77
Number of sells: 46

Quarterly Holders Quick Answers

What is CUSIP 04280A100?
CUSIP 04280A100 identifies ARWR - ARROWHEAD PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2018
Previous quarter: Q1 2018

Recent filing periods for CUSIP 04280A100:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ARWR - ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
OppenheimerFunds, Inc.	13F	Company	5.8%	7,807,644	$56,293,000	—	31 Mar 2018	13F
FIRST MANHATTAN CO. LLC.	13F	Company	3.3%	4,530,250	$32,663,000	—	31 Mar 2018	13F
VANGUARD GROUP INC	13F	Company	2.5%	3,434,112	$24,760,000	—	31 Mar 2018	13F
BlackRock Finance, Inc.	13F	Company	2.5%	3,403,940	$24,543,000	—	31 Mar 2018	13F
RTW INVESTMENTS, LP	13F	Company	2.2%	2,916,561	$21,028,000	—	31 Mar 2018	13F
STATE STREET CORP	13F	Company	1.9%	2,553,431	$18,411,000	—	31 Mar 2018	13F
Vivo Capital, LLC	13F	Company	1.4%	1,900,000	$13,699,000	—	31 Mar 2018	13F
ACUTA CAPITAL PARTNERS, LLC	13F	Company	1.3%	1,762,206	$12,706,000	—	31 Mar 2018	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	1.1%	1,503,500	$10,840,000	—	31 Mar 2018	13F
NEXTHERA CAPITAL LP	13F	Company	0.82%	1,114,097	$8,033,000	—	31 Mar 2018	13F
D. E. Shaw & Co., Inc.	13F	Company	0.66%	891,784	$6,430,000	—	31 Mar 2018	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.6%	817,317	$5,893,000	—	31 Mar 2018	13F
Ghost Tree Capital, LLC	13F	Company	0.59%	800,000	$5,768,000	—	31 Mar 2018	13F
Uniplan Investment Counsel, Inc.	13F	Company	0.53%	724,228	$5,221,000	—	31 Mar 2018	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.47%	630,631	$4,546,000	—	31 Mar 2018	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.4%	542,726	$3,913,000	—	31 Mar 2018	13F
PDT Partners, LLC	13F	Company	0.34%	459,400	$3,312,000	—	31 Mar 2018	13F
PERCEPTIVE ADVISORS LLC	13F	Company	0.27%	365,445	$2,635,000	—	31 Mar 2018	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.2%	273,042	$1,969,000	—	31 Mar 2018	13F
BlueCrest Capital Management Ltd	13F	Company	0.18%	246,490	$1,777,000	—	31 Mar 2018	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.18%	244,065	$1,760,000	—	31 Mar 2018	13F
DEUTSCHE BANK AG\	13F	Company	0.17%	236,845	$1,707,000	—	31 Mar 2018	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.17%	234,500	$1,691,000	—	31 Mar 2018	13F
NORTHERN TRUST CORP	13F	Company	0.16%	221,517	$1,597,000	—	31 Mar 2018	13F
UBS Group AG	13F	Company	0.15%	202,765	$1,462,000	—	31 Mar 2018	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.15%	200,000	$1,442,000	—	31 Mar 2018	13F
Iguana Healthcare Management, LLC	13F	Company	0.15%	200,000	$1,442,000	—	31 Mar 2018	13F
MORGAN STANLEY	13F	Company	0.13%	182,113	$1,314,000	—	31 Mar 2018	13F
Tibra Equities Europe Ltd	13F	Company	0.13%	171,033	$1,233,000	—	31 Mar 2018	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.1%	133,969	$966,000	—	31 Mar 2018	13F
BARCLAYS PLC	13F	Company	0.1%	130,172	$938,000	—	31 Mar 2018	13F
CITIGROUP INC	13F	Company	0.09%	122,464	$883,000	—	31 Mar 2018	13F
ELEMENT CAPITAL MANAGEMENT LLC	13F	Company	0.09%	118,051	$851,000	—	31 Mar 2018	13F
ALPS ADVISORS INC	13F	Company	0.09%	116,402	$839,000	—	31 Mar 2018	13F
A.R.T. Advisors, LLC	13F	Company	0.07%	100,470	$724,000	—	31 Mar 2018	13F
Laurion Capital Management LP	13F	Company	0.07%	100,281	$723,000	—	31 Mar 2018	13F
BLAIR WILLIAM & CO/IL	13F	Company	0.07%	92,850	$669,000	—	31 Mar 2018	13F
Bank of New York Mellon Corp	13F	Company	0.06%	77,038	$555,000	—	31 Mar 2018	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.06%	74,678	$539,000	—	31 Mar 2018	13F
ClariVest Asset Management LLC	13F	Company	0.05%	70,400	$507,000	—	31 Mar 2018	13F
GROUP ONE TRADING LLC	13F	Company	0.05%	68,738	$496,000	—	31 Mar 2018	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.05%	67,257	$485,000	—	31 Mar 2018	13F
First Allied Advisory Services, Inc.	13F	Company	0.05%	61,000	$440,000	—	31 Mar 2018	13F
Marshall Wace North America L.P.	13F	Company	0.04%	60,760	$438,000	—	31 Mar 2018	13F
TIVERTON ASSET MANAGEMENT LLC	13F	Company	0.04%	60,202	$434,000	—	31 Mar 2018	13F
Silphium Asset Management Ltd	13F	Company	0.04%	53,012	$382,217	—	31 Mar 2018	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.03%	44,358	$320,000	—	31 Mar 2018	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.03%	40,452	$291,000	—	31 Mar 2018	13F
ProShare Advisors LLC	13F	Company	0.03%	40,127	$289,000	—	31 Mar 2018	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.03%	37,900	$273,000	—	31 Mar 2018	13F

Institutional Holders of ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (ARWR) as of Q2 2018

As of 30 Jun 2018, ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (ARWR) was held by 114 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 51,724,461 shares. The largest 10 holders included RTW INVESTMENTS, LP, OppenheimerFunds, Inc., BlackRock Inc., FIRST MANHATTAN CO, STATE STREET CORP, VANGUARD GROUP INC, Vivo Capital, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., NORTHERN TRUST CORP, and ACUTA CAPITAL PARTNERS, LLC. This page lists 114 institutional shareholders reporting positions in this security for the Q2 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2018 vs Q1 2018 Across Filers

Q1 2018 holders

Q2 2018 holders

114

Holder diff

Investor	Q1 2018 Shares	Q2 2018 Shares	Share Diff	Share Chg %	Q1 2018 Value $	Q2 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.